Response to 'Is the case really a SMARCA4-deficient thoracic sarcoma?'

Thorac Cancer. 2021 Jan;12(1):141. doi: 10.1111/1759-7714.13751. Epub 2020 Nov 18.

Authors

Kohichi Takada¹, Shintaro Sugita², Tadashi Hasegawa²

Affiliations

¹ Department of Medical Oncology, Sapporo Medical University School of Medicine, Sapporo, Japan.
² Department of Surgical Pathology, Sapporo Medical University School of Medicine, Sapporo, Japan.

No abstract available

Publication types

Letter
Comment

MeSH terms

Antibodies, Monoclonal, Humanized
B7-H1 Antigen*
DNA Helicases
Humans
Nuclear Proteins
Sarcoma* / genetics
Transcription Factors

Substances

Antibodies, Monoclonal, Humanized
B7-H1 Antigen
Nuclear Proteins
Transcription Factors
pembrolizumab
SMARCA4 protein, human
DNA Helicases